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ABSTRACT
Solitary fibrous tumor (SFT) is a mesenchymal neoplasm that appears primarily in the pleura and rarely in intrapulmonary 
or endobronchial topography. The authors report the case of a 47-year-old woman who presented obstructive respiratory 
symptoms for 4 years. The chest computed tomography and bronchoscopy showed an obstructive polypoid lesion located 
between the trachea and the left main bronchus associated with distal atelectasis of the left lung. A resection of the 
lesion was performed and, macroscopically, the mass was oval, encapsulated, and firm, measuring 2.3 × 1.7 × 1.5 cm. 
Histology revealed low-grade mesenchymal spindle cell neoplasm, with alternating cellularity, myxoid areas, and mature 
adipose tissue outbreaks, as well as blood vessels with irregular walls. The immunohistochemical study was positive for 
CD34, CD99, and BCL2. The diagnosis was SFT in an unusual topography. The patient’s symptoms remitted after tumor 
excision, and no systemic problems were evident. SFTs primarily affect adults and often follow a benign course; however, 
their behavior is unpredictable. The presence of necrosis and mitotic activity may portend a poor prognosis. Endobronchial 
SFTs are rare but should be evaluated and monitored similar to SFTs at other sites, with a long-term follow-up. 
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INTRODUCTION
Solitary fibrous tumor (SFT) is an uncommon soft 
tissue spindle cell neoplasm with distinctive histology 
and immunohistochemistry, which is first recognized 
in the visceral pleura. However, it has been described 
as originating from many other sites also, such as 
subcutaneous tissue, deep soft tissues, the head, 
neck, chest wall, lung, mediastinum, meninges, and 
the abdominal cavity.1,2 Pak et al.,3 in a review of 
the literature, found 800 descriptions of STF in the 
pleura, 15 in the lung parenchyma, and only 2 in an 
endobronchial location.
CASE REPORT
A 47-year-old Caucasian woman was diagnosed 
with late-onset asthma because of a 4-year history 
of wheezing and productive cough sputum. Despite 
the asthma treatment, the patient’s symptoms 
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progressively worsened with episodes of pain in the left 
hemithorax, and dyspnea with unidentified triggering 
agents. The patient had no previous or relevant family 
health problems. The physical examination of the chest 
showed bilateral vesicular breath sounds that were 
decreased in the left base.
Chest radiography showed a marked volume 
reduction of the left lung. In a chest computed 
tomography scan, a rounded lesion was evident, which 
was partially obstructing the ostium of the left main 
bronchus (Figure 1A).
The patient underwent a rigid bronchoscopy, 
which found a mobile polypoid lesion that adhered to 
the bronchial mucosa. It had a smooth shiny surface, 
was not friable, and obstructed the left main bronchus 
(Figure 1B). It was removed endoscopically.
On gross examination, the lesion was oval-shaped, 
well circumscribed, encapsulated, with a fibroelastic 
consistency, and measured 2.3 × 1.7 × 1.5 cm 
and weighed 5.0 g. The cut surface was smooth, 
homogeneous, and brownish in color (Figure 2A). 
All material was sampled for microscopic evaluation.
Figure 1. A - Chest CT axial plane showing reduced volume of the left lung and an obstructive lesion (arrow) at the 
carina obstructing the emergence of the left main bronchus; B - Endoscopic view of the polypoid lesion observed 
within the left main bronchus.
Figure 2. A - Macroscopic view of the light-brownish oval lesion with a bright and irregular surface; 
B - Photomicrography of the tumor; histologic section showing varied cellularity of the neoplasia. Note the absence 
of necrosis (H&E, 50X).
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Histological sections of this material showed 
low-grade mesenchymal neoplasm without cellular 
atypia or necrosis, represented by spindle cells 
arranged in small, loose, fascicular arrangements, with 
hypercellular and hypocellular areas (Figures 2B and 3A). 
The hypocellular areas had dense collagen bands and 
focal myxoid changes. There were focal aggregates 
of mature fat cells. Blood vessels were irregular in 
shape and focally showed a “staghorn” configuration 
(Figures 3B, 3C, 3D).
The mitotic counting was 2 per 10 high-power 
f i e l d s .  T h e  m o r p h o l o g i c a l  f i n d i n g s  w e r e 
consistent with a benign spindle cell neoplasm. 
The immunohistochemical study revealed negativity 
for cytokeratin (AE1/AE3), S100 protein, smooth 
muscle actin, and desmin. The neoplastic cells were 
positive for CD34, CD99, and BCL2 (Figure 4A, 4B, 4C, 
respectively). The histological features were consistent 
with the diagnosis of SFT. The patient became 
asymptomatic after the lesion’s excision, and during 
Figure 3. Photomicrography of the tumor. A - Hypercellular neoplastic area; spindle cells with minimal atypia. 
Note the absence of mitotic activity (H&E, 400X); B - Area of less intense cellularity, with dense collagen and focal 
myxoid degeneration (H&E, 200X); C - Blood vessels with “staghorn” configuration (H&E, 200X); D – Spotlights of 
mature adipose tissue within the fusocellular neoplastic areas (H&E, 200X).
Figure 4. Photomicrography of the tumor. Immunohistochemistry: A - Positivity for CD 34 (400X); B - Positivity for 
CD 99 (400X); C - Positivity for BCL 2 (200X).
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the 18-month follow-up no other lesions were 
detected.
DISCUSSION
SFT is a mesenchymal neoplasm, often with 
a hemangiopericytic pattern,1,2,4 and framed in 
the group of soft tissue tumors as of uncertain 
histological type and indeterminate malignancy.1 
This group of tumors also comprises the ossifying 
fibromyxoid tumor, the mixoinflammatory fibroblast 
sarcoma, the pleomorphic hyalinizing angiectatic 
tumor, and the phosphaturic mesenchymal tumor.1 
The World Health Organization has classified SFT in 
the group of fibroblastic/myofibroblastic tumors.2 
Since the initial descriptions of this neoplasm, there 
has been a discussion on the use of the terminology 
hemangiopericytoma/SFT; currently, SFT is the 
preferred nomenclature.1,2
This tumor usually affects adults aged between 
20 and 70 years, with no gender preference. The clinical 
behavior is represented by a painless and slow-growing 
mass, which is eventually associated with compressive 
symptoms.1,2 In the case reported herein, the patient 
had an obstruction to the respiratory airway, which 
was clinically misdiagnosed as late-onset asthma.
Macroscopically, these tumors may be encapsulated 
and they are well-circumscribed, sometimes forming 
nodules (as noted in visceral topographies), or 
appearing as exophytic masses (as seen in serous 
surfaces). In general, the size varies between 5.0 cm 
and 10.0 cm, the color is grayish-white, and there 
is eventual central bleeding and/or necrotic foci. 
Histologic evaluation reveals varying cell density 
composed of spindle cells with rounded nuclei, and 
indistinct cytoplasm with or without mild atypia. Focal 
hyalinization and thickening of the vessel walls have 
often been observed and, together with the branch 
and irregularities of vascular walls (staghorn-like 
vascular network), this gives the hemangiopericytic-like 
pattern to the lesion.1,2 Varying proportions of myxoid 
patterns are also reported.5,6 The presence of mature 
adipose tissue foci has already been described, mainly 
in the variant called “fat-forming,” which has a similar 
outcome and prognosis.7
Regarding the immunohistochemical evaluation, 
three markers have been highlighted: CD34, CD99, 
and BCL2, which are positive in 90%, 70%, and 30% 
of cases, respectively. Variable positivity is described for 
epithelial membrane antigen and smooth muscle actin. 
Markers, such as desmin, S100 protein, and cytokeratin, 
are necessarily negative.2 Recently, Bouvier et al.8 
described the overexpression of the ALDH1 gene in 
84% of cases of SFT. They observed high sensitivity 
and specificity of the immunohistochemistry for the 
detection of this gene product for the diagnosis of 
SFT, especially when associated with the standard 
markers of this neoplasm.8 This research emphasized 
their use, particularly in the meninges topography to 
differentiate it from meningioma, because only 1.2% 
of meningothelial tumors have an overexpression of 
this gene.8
Unlike other soft tissue tumors, which have 
specific chromosomal/genetic alterations, SFT does 
not have well-defined molecular abnormalities 
Recently, the literature highlighted gene fusion NAB2/
STAT6, associated with deregulation of the NAB2 
gene—a gene regulator of the early growth response 
1 transcription factor.9,10
The intrapulmonary or endobronchial location 
of this tumor is unusual.4,9 Rao et al.4 described the 
clinical, morphological, and immunophenotypic 
characteristics of 24 cases of intrapulmonary SFT.4 
They emphasized that the appearance of these tumors 
in topography may be related to (i) direct continuity 
between the mesenchyme and subpleural pulmonary 
interlobular septa; (ii) parenchymal lung fibroblasts; or 
(iii) invaginations of the visceral pleura.4
In the case presented herein, the presence of 
myxoid areas and adipose tissue associated with 
the fibrous component gave rise to the differential 
diagnosis of a bronchial lipomatous tumor (i.e. 
adipocytes lesion with discrete cellular atypia). 
Boland et al.,11 in a study of such cases, showed that 
even the most atypical lesions reveal a cytogenetic 
profile consistent with lipomas, and they emphasized 
that liposarcoma, in this location, is quite unusual. 
Spindle cell lipoma, a lesion with a variable proportion 
of adipose tissue, is another differential diagnosis. 
However, it rarely originates in deep topographies and 
it lacks the typical irregular shape of the vasculature.2,12 
Myofibroblastoma, a common cancer in the breast 
and abdominal wall, also could be a possibility, but it 
presents positivity for desmin, which is not observed 
in SFT.2,12,13 It should be noted that SFT, spindle cell 
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lipoma, and myofibroblastoma are neoplasms with 
overlapping morphology and immunophenotype 
features. The expression of CD34 in these tumors 
emphasizes the plasticity of differentiation of these 
cells.12,13
The majority of patients with SFT have a benign 
course following excision. The two most important 
criteria for bad prognostic predictors are mitotic activity 
(more than 4 mitoses in 10 high-power fields) and 
necrosis.1,2 Other criteria for bad prognosis include a 
tumor size > 5.0 cm, marked cellularity, hemorrhage, 
and cellular pleomorphism.1 Rao et al.,4 in a study 
of patients with intrapulmonary SFT, showed that 
even tumors with mild atypia and lacking mitotic 
activity or necrosis rarely fare poorly. Therefore, 
excision and careful clinical follow-up are essential. 
DeMicco et al.,14 after a study at the MD Anderson 
Cancer Center, proposed a risk stratification model 
based on age (cut-off: 55 years), size (< 5.0 cm, 
5.0-10 cm, 10-15 cm, ≥ 15 cm), and mitotic activity 
(0, 1-3 mitoses, and ≥ 4 mitoses). Each item gives a 
score, rendering a classification of low risk (0-2 points), 
moderate risk (3-4 points), and high risk (5-6 points).14 
Low-risk patients had an absence of metastases and 
100% survival after 5 and 10 years. However, high-risk 
patients showed only a 15% free rate of metastatic 
disease after 5 years, 60% survival after 5 years, and 
0% survival after 10 years.14 Our patient was classified 
as low-risk; therefore, rigorous clinical monitoring was 
recommended.
SFT is a compelling neoplasm for clinicians, 
surgeons, and pathologists, and is often difficult to 
diagnose. In this case, the challenge was imposed 
by the location and the morphologic variation with 
focal adipose tissue and myxoid changes. This report 
highlights the importance of careful morphological 
evaluation in risk stratification to predict the biological 
behavior of this lesion.
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